No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Jagsonpal Pharmaceuticals Limited, an Indian company founded in 1964 and based in New Delhi, specializes in the development and manufacturing of both bulk active pharmaceutical ingredients and diverse medicinal formulations. Its product portfolio spans three primary therapeutic domains: women's health, pain management and analgesia, and general medical care. Within general medicine, the company offers solutions for allergy control, immune and cellular protection, gastrointestinal and mental wellness, anti-infectives, and products specifically for dental and ear, nose, and throat (ENT) conditions. For women's healthcare, their offerings include pregnancy support and treatments for issues related to dysfunctional uterine bleeding. Furthermore, Jagsonpal provides medications for pain relief and skeletal and joint health. These pharmaceutical items are supplied in common forms like tablets, capsules, and syrups. The company operates as a subsidiary under Aresko Progressive Private Limited.
www.jagsonpal.comNo one on the platform currently holds JAGSNPHARM.NS.
No tracked institution reports a position in JAGSNPHARM.NS as of their last filing.
No one on the platform has traded JAGSNPHARM.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| JAGSNPHARM.NSJagsonpal Pharmaceuticals Limited | $228.28 | +1.08% | $15.0B | — |
| BAJAJHCARE.BOBajaj Healthcare Ltd | $320.95 | +0.19% | $10.7B | — |
| BAJAJHCARE.NSBajaj Healthcare Ltd | $321.10 | +0.06% | $10.8B | — |
| BLISSGVS.BOBliss GVS Pharma Limited | $679.90 | -0.94% | $72.5B | — |
| BLISSGVS.NSBliss GVS Pharma Limited | $680.50 | -0.65% | $72.2B | — |
| HESTERBIO.BOHester Biosciences Limited | $2184.70 | +0.78% | $18.6B | — |
| HESTERBIO.NSHester Biosciences Limited | $2207.70 | +1.65% | $18.8B | — |
Source: Financial Modeling Prep · peers by sector/industry